Health Care: Drugs

Redhill Biopharma Ltd (RDHL: NASDAQ)

$14.37 -0.2201 | -1.51%
07/28/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 14.59
52 Week High 21.00
52 Week Low 9.01
Avg. Daily Vol. (Mil) 0.01
Beta (3 year) 0.00
Share Related Items
Mkt Cap (Mil) 127.50
Shares Out (Mil) 8.74
Float (Mil) 0.00
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 8.90
Current Ratio 9.80
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 18.18
Price/Book 3.79
Price/Cash Flow -17.70
Per Share Data
Earnings -1.12
Sales 0.80
Book Value 3.85
Cash Flow -0.83
Business Summary
Redhill Biopharma Ltd is a biopharmaceutical company. It develops & acquires late clinical-stage, proprietary formulations & combinations of existing drugs. Its products include drugs for high blood pressure & vomiting prevention, among others.
General Information
21 Ha'arba'a Street
Tel Aviv, 64739
www.redhillbio.com
Industry : Drugs
Sector: Health Care
Employees: 8
CEO: Mr. Dror Ben-Asher
Short Interest
Current Month (Mil) 0.00
Previous Month (Mil) 0.00
Short Interest Ratio (Days) 0.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -18.60
Return on Investments -21.60
Profitability
Gross Margin 86.10
EBIT Margin -96.20
Profit Margin 0.00

Partner Headlines for RDHL

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter